Clinical Trial: Clinical study on the use of Romiplostim N01 for the secondary prevention of thrombocytopenia caused by concurrent chemoradiotherapy in gynecological malignancies (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study on the use of Romiplostim N01 for the secondary prevention of thrombocytopenia caused by concurrent chemoradiotherapy in gynecological malignancies'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134172

Registration Time: 2026/10/11

Type: Interventional study

Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=311245

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical study on the use of Romiplostim N01 for the secondary prevention of thrombocytopenia caused by concurrent chemoradiotherapy in gynecological malignancies (China)